147 related articles for article (PubMed ID: 16293272)
1. Selective impairment of sadness and disgust recognition in abstinent ecstasy users.
Yip JT; Lee TM
Neuropsychologia; 2006; 44(6):959-65. PubMed ID: 16293272
[TBL] [Abstract][Full Text] [Related]
2. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
[TBL] [Abstract][Full Text] [Related]
3. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
[TBL] [Abstract][Full Text] [Related]
5. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
6. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
Medina KL; Shear PK; Corcoran K
J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
[TBL] [Abstract][Full Text] [Related]
7. The acute and sub-acute effects of 'ecstasy' (MDMA) on processing of facial expressions: preliminary findings.
Hoshi R; Bisla J; Curran HV
Drug Alcohol Depend; 2004 Dec; 76(3):297-304. PubMed ID: 15561480
[TBL] [Abstract][Full Text] [Related]
8. Visuo-spatial working memory deficits in current and former users of MDMA ('ecstasy').
Wareing M; Fisk JE; Murphy P; Montgomery C
Hum Psychopharmacol; 2005 Mar; 20(2):115-23. PubMed ID: 15641126
[TBL] [Abstract][Full Text] [Related]
9. Intensity-dependent facial emotion recognition and cognitive functions in Parkinson's disease.
Assogna F; Pontieri FE; Cravello L; Peppe A; Pierantozzi M; Stefani A; Stanzione P; Pellicano C; Caltagirone C; Spalletta G
J Int Neuropsychol Soc; 2010 Sep; 16(5):867-76. PubMed ID: 20663240
[TBL] [Abstract][Full Text] [Related]
10. The processing of emotion in patients with Huntington's disease: variability and differential deficits in disgust.
Hayes CJ; Stevenson RJ; Coltheart M
Cogn Behav Neurol; 2009 Dec; 22(4):249-57. PubMed ID: 19996878
[TBL] [Abstract][Full Text] [Related]
11. The association between the negative effects attributed to ecstasy use and measures of cognition and mood among users.
Fisk JE; Montgomery C; Murphy PN
Exp Clin Psychopharmacol; 2009 Oct; 17(5):326-36. PubMed ID: 19803632
[TBL] [Abstract][Full Text] [Related]
12. Impact of severity of drug use on discrete emotions recognition in polysubstance abusers.
Fernández-Serrano MJ; Lozano O; Pérez-García M; Verdejo-García A
Drug Alcohol Depend; 2010 Jun; 109(1-3):57-64. PubMed ID: 20064697
[TBL] [Abstract][Full Text] [Related]
13. Facial emotion recognition impairment in chronic temporal lobe epilepsy.
Meletti S; Benuzzi F; Cantalupo G; Rubboli G; Tassinari CA; Nichelli P
Epilepsia; 2009 Jun; 50(6):1547-59. PubMed ID: 19175397
[TBL] [Abstract][Full Text] [Related]
14. Explicit identification and implicit recognition of facial emotions: II. Core domains and relationships with general cognition.
Mathersul D; Palmer DM; Gur RC; Gur RE; Cooper N; Gordon E; Williams LM
J Clin Exp Neuropsychol; 2009 Apr; 31(3):278-91. PubMed ID: 18720178
[TBL] [Abstract][Full Text] [Related]
15. Self reported sleep quality and cognitive performance in ecstasy users.
Montgomery C; Fisk JE; Wareing M; Murphy P
Hum Psychopharmacol; 2007 Dec; 22(8):537-48. PubMed ID: 17960556
[TBL] [Abstract][Full Text] [Related]
16. Emotion recognition in Huntington's disease and frontotemporal dementia.
Snowden JS; Austin NA; Sembi S; Thompson JC; Craufurd D; Neary D
Neuropsychologia; 2008 Sep; 46(11):2638-49. PubMed ID: 18533200
[TBL] [Abstract][Full Text] [Related]
17. The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users.
Fagundo AB; Cuyàs E; Verdejo-Garcia A; Khymenets O; Langohr K; Martín-Santos R; Farré M; de la Torre R
J Psychopharmacol; 2010 Sep; 24(9):1381-93. PubMed ID: 20080926
[TBL] [Abstract][Full Text] [Related]
18. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
Bedi G; Redman J
Psychol Med; 2008 Sep; 38(9):1319-30. PubMed ID: 18226286
[TBL] [Abstract][Full Text] [Related]
19. Effect of ecstasy use on neuropsychological function: a study in Hong Kong.
Yip JT; Lee TM
Psychopharmacology (Berl); 2005 May; 179(3):620-8. PubMed ID: 15650845
[TBL] [Abstract][Full Text] [Related]
20. Executive working memory deficits in abstinent ecstasy/MDMA users: a critical review.
Murphy PN; Wareing M; Fisk JE; Montgomery C
Neuropsychobiology; 2009; 60(3-4):159-75. PubMed ID: 19893333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
